Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)

Respiratory Syncytial Virus Bronchiolitis Clinical Trial

Official title: An Observational Follow-Up Study of Pediatric Patients Who Participated in a Previous Respiratory Syncytial Virus (RSV)-Induced Bronchiolitis Study of Montelukast

Status Completed

Clinical Trial Summary

This is a prospective, multicenter, observational study in participants who completed the 24-week, placebo-controlled MK-0476 Protocol 272 (NCT00076973) study of montelukast in the treatment of respiratory symptoms subsequent to RSV-induced bronchiolitis. The purpose of this study is to better understand the clinical and demographic correlates of asthma and atopic disorders in children (through the age of 6 years) with a history of severe RSV-induced bronchiolitis.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Bronchiolitis
• Respiratory Syncytial Virus Bronchiolitis

• NCT number: NCT01140048
• Study type: Observational
• Source: Organon and Co
• Status: Completed
• Start date: October 2007
• Completion date: October 2011